Sumitovant Biopharma to buy Myovant for $27 per share

Sumitomo Pharma

24/10/2022 04:43

Oct 23 (Reuters) - Sumitovant Biopharma Ltd, along with
parent Sumitomo Pharma Co Ltd  4506.T , has entered into a deal
to purchase all shares of Myovant Sciences  MYOV.N  not already
owned by Sumitovant for $27 per share, the companies said in a
statement on Sunday.
 (Reporting by Ann Maria Shibu in Bengaluru; Editing by Shailesh
Kuber)
 ((AnnMaria.Shibu@thomsonreuters.com; +1 646 223 8780;  + 91 80
6749 2795;))